Mesenchymal Stem Cell Therapy for Severe COVID-19 ARDS.

Helene HäberleHarry MaguniaPeter LangHenning GloecknerAndreas KörnerMichael KoeppenTamam BackchoulNisar MalekRupert HandgretingerPeter RosenbergerValbona Mirakaj

Published in: Journal of intensive care medicine (2021)

MSC infusion is a safe treatment for COVID-19 ARDS that improves pulmonary function and overall outcome in this patient population.

Keyphrases

coronavirus disease
sars cov
acute respiratory distress syndrome
extracorporeal membrane oxygenation
mesenchymal stem cells
mechanical ventilation
respiratory syndrome coronavirus
bone marrow
early onset
stem cells
umbilical cord